(Q38185614)

30 August 2017

0 references

Diagnostic value of phospholipase A2 receptor in idiopathic membranous nephropathy: a systematic review and meta-analysis (English)

1 reference

30 August 2017

1 reference

1 reference

1 reference

Shou-Liang Hu

1

1 reference

30 August 2017

Dan Wang

2

1 reference

30 August 2017

Wen-Jun Gou

3

1 reference

30 August 2017

Qing-Feng Lei

4

1 reference

30 August 2017

Te-An Ma

5

1 reference

30 August 2017

Jun-Zhang Cheng

6

1 reference

30 August 2017

publication date

6 February 2014

1 reference

30 August 2017

published in

Journal of Nephrology

1 reference

30 August 2017

volume

27

1 reference

30 August 2017

issue

2

1 reference

30 August 2017

page(s)

111-116

1 reference

https://scigraph.springernature.com/pub.10.1007/s40620-014-0042-7

30 August 2017

exact match

0 references

cites work

The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0042-7

Recent advances and prognosis in idiopathic membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0042-7

Molecular pathomechanisms of membranous nephropathy: from Heymann nephritis to alloimmunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0042-7

Controversies in the treatment of idiopathic membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0042-7

Structure and function of phospholipase A2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0042-7

Phospholipase A2 receptor: a regulator of biological functions of secretory phospholipase A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0042-7

M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0042-7

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0042-7

Anti-phospholipase A2 receptor antibody in membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0042-7

Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0042-7

An anti-phospholipase A2 receptor quantitative immunoassay and epitope analysis in membranous nephropathy reveals different antigenic domains of the receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0042-7

Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0042-7

Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0042-7

Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0042-7

Activation of cytokine production by secreted phospholipase A2 in human lung macrophages expressing the M-type receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0042-7

Presence of the M-type sPLA(2) receptor on neutrophils and its role in elastase release and adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0042-7

Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0042-7

Membranous nephropathy: recent travels and new roads ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0042-7

Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0042-7

Autoimmunity in membranous nephropathy targets aldose reductase and SOD2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0042-7

Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: Alfa-enolase and borderline antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0042-7

PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy

21 January 2018

1 reference

12 December 2020

An immunofluorescence test for phospholipase-A₂-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis

1 reference

12 December 2020

Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies

1 reference

12 December 2020

Molecular cloning of pancreatic group I phospholipase A2 receptor.

1 reference

12 December 2020

10.1007/S40620-014-0042-7

Identifiers

DOI

1 reference

Dimensions Publication ID

30 August 2017

1052805435

0 references

1 reference